Tag Archives: REGN

Oppenheimer Keeps a Buy Rating on Regeneron (REGN)

Oppenheimer analyst Hartaj Singh maintained a Buy rating on Regeneron (REGN – Research Report) yesterday and set a price target of $440. The company’s shares closed on Friday at $365.65. Singh noted: “We met with members of the REGN mgmt

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN) and SeaSpine Holdings (NASDAQ: SPNE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regeneron (REGN – Research Report) and SeaSpine Holdings (SPNE – Research Report). Regeneron (REGN) J.P. Morgan analyst Cory Kasimov assigned a Hold rating

New Buy Rating for Regeneron (REGN), the Healthcare Giant

Oppenheimer analyst Hartaj Singh maintained a Buy rating on Regeneron (REGN – Research Report) yesterday and set a price target of $440. The company’s shares closed yesterday at $357.61. Singh observed: “Regeneron (REGN) reported 3Q18 sales/earnings and provided a business

Regeneron (REGN) Receives a Hold from Cowen & Co.

In a report released today, Phil Nadeau from Cowen & Co. maintained a Hold rating on Regeneron (REGN – Research Report), with a price target of $385. The company’s shares opened today at $357.61. According to TipRanks.com, Nadeau is a

Cowen & Co. Remains a Hold on Regeneron (REGN)

Cowen & Co. analyst Phil Nadeau maintained a Hold rating on Regeneron (NASDAQ: REGN) yesterday and set a price target of $385. The company’s shares opened today at $387.80. According to TipRanks.com, Nadeau is a 5-star analyst with an average

Regeneron (REGN) Receives a Hold from J.P. Morgan

In a report issued on September 28, Cory Kasimov from J.P. Morgan maintained a Hold rating on Regeneron (NASDAQ: REGN). The company’s shares closed yesterday at $394.23. According to TipRanks.com, Kasimov is a 3-star analyst with an average return of